An investigation of the anti-inflammatory effects and a potential biomarker of PI3Kδ inhibition in COPD T cells

Clinical and Experimental Pharmacology & Physiology
Abid KhanD Singh

Abstract

Lymphocyte numbers are increased in the lungs of chronic obstructive pulmonary disease (COPD) patients. Phosphatidylinositol-3-kinase delta (PI3Kδ) is involved in lymphocyte activation. We investigated the effect of PI3Kδ inhibition on cytokine release from COPD lymphocytes. We also evaluated phosphorylated ribosomal S6 protein (rS6) as a potential biomarker of PI3Kδ activation. Peripheral blood mononuclear cells (PBMCs) and bronchoalveolar lavage (BAL) cells isolated from healthy never smokers (HNS), smokers (S) and COPD patients were stimulated to induce a T cell receptor response. The effects of a PI3Kδ specific inhibitor (GSK045) on cytokine release and rS6 phosphorylation were measured by Luminex and flow cytometry respectively. The effects of GSK045 on cytokine production from PHA stimulated chopped lung samples were investigated. GSK045 reduced cytokine release from PBMCs, BAL cells and chopped lung. Inhibition was greatest in the chopped lung model, with approximately 80% inhibition of interferon (IFN) γ, interleukin (IL)-2, IL-17 and IL-10. PI3Kδ inhibition suppressed rS6 phosphorylation in unstimulated airway T-lymphocytes by up to 60%. Inhibition of PI3Kδ suppressed T cell cytokine production in COPD patients. rS6 ph...Continue Reading

References

Apr 9, 2002·The European Respiratory Journal·M LaanA Lindén
Jun 11, 2002·Biochemical and Biophysical Research Communications·Jason A Lehman, Julian Gomez-Cambronero
Mar 28, 2003·Nature Immunology·Shigeo Koyasu
Apr 2, 2003·Nature Reviews. Immunology·Klaus Okkenhaug, Bart Vanhaesebroeck
Sep 30, 2003·Thorax·A AgustíM Cosio
Jun 25, 2004·The New England Journal of Medicine·James C HoggPeter D Paré
Feb 19, 2005·Science·D D SarbassovDavid M Sabatini
Mar 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kyung S LeeKamal D Puri
Jun 6, 2006·The Journal of Allergy and Clinical Immunology·Adam BarczykPeter J Barnes
Oct 21, 2006·Biochemical Society Transactions·P T HawkinsL R Stephens
Dec 22, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dapeng Gong, Thomas R Malek
Jul 7, 2007·Immunology·David A Medina-TatoMalcolm L Watson
Nov 18, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Robert J SalmondRose Zamoyska
Mar 13, 2010·American Journal of Respiratory and Critical Care Medicine·Yasuo ToPeter J Barnes
Oct 14, 2010·Cellular Signalling·Wai-Ping Fung-Leung
Mar 16, 2012·Respiratory Research·Manminder KaurDave Singh
Aug 11, 2012·American Journal of Respiratory and Critical Care Medicine·Jørgen VestboRoberto Rodriguez-Roisin
Apr 5, 2013·Annals of the New York Academy of Sciences·Srividya SriskantharajahAugustin Amour
Mar 19, 2014·The Journal of Allergy and Clinical Immunology·Javier MilaraJulio Cortijo
May 15, 2016·Seminars in Immunopathology·Gaetano CaramoriIan Adcock

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.